Kim Quimby, MBBS, MSc, PhD

Role: Lecturer, Immunology

Kim Quimby is a clinician-scientist who graduated with a Bachelor in Medicine and Surgery from the University of the West Indies in 2001 and a Masters in Immunology from Kings College London in 2006. She returned to Barbados in 2007 where she joined the George Alleyne Chronic Disease Research Centre (GA-CDRC), University of the West Indies, as a Lecturer in Immunology responsible for delivering modules to the first and fourth year medical students. Since 2009, she has been enrolled in the PhD (Immunology) programme.

Dr Quimby has presented outcomes of her research at multiple local, regional and international scientific meetings. She is the Chair of the UWI / Barbados Association of Medical Practitioners Continuing Medical Education (CME) committee, member of the Barbados Medical Council CME committee and Curriculum coordinator of the Caribbean Cytometry and Analytical Society.

Research interests

Her interests include molecular pathway of diseases which are of particular relevance to the Caribbean region; namely sickle cell disease and type-2 diabetes.

Selected publications

  • Quimby KR, Hambleton IR, Landis RC. Intravenous infusion of Haptoglobin for the prevention of adverse clinical outcome in Sickle Cell Disease. Medical Hypotheses. Medical Hypotheses. 2015;85:424-432
  • Quimby KR, Moe S, Sealy I, Nicholls C, Hambleton IR, Landis RC. Clinical findings associated with Homozygous Sickle cell disease in the Barbadian population - Do we need a national SCD registry? BMC Research notes. 2014;7:102
  • Quimby KR, Flower C, Hambleton IR, Landis RC, Hennis AJM. Comparison of the Systemic Lupus Erythematosus Activity Questionnaire and the Systemic Lupus Erythematosus Disease Activity Index in A Black Barbadian Population. International Journal of Rheumatology. Volume 2013 (2013), Article ID 875369, 5 pages.
  • Quimby KR, Greenidge AR, Hennis AJM, Harrison DK, Landis RC. Tumor Necrosis Factor Receptor Associated Periodic Syndrome P46L and bilateral amputation in diabetes. Rheumatology (Oxford). 2010;49(12):2454-5.
  • Quimby KR, Greenidge AR, Harris A, Landis RC. Phenotypic commitment of monocytes towards a protective hemoglobin scavenging phenotype (CD14posCD163highHLA-DRlow) following cardiopulmonary bypass. Cytometry B Clin Cytom. 2010;78(5):357-60.
Back to top